Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc.

AMLX · Nasdaq

Amylyx Pharmaceuticals, Inc. (AMLX) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Amylyx Pharmaceuticals, Inc. in 2026. The next earnings report is expected on November 5, 2026.

Earnings calendar

Next earnings date

05 Nov 2026

In 76 days

EPS estimate

-0.35

Revenue estimate

69.3K

Past earnings

06 Aug 2026
EPS actual
-0.39 (-8.1%)
estimate -0.36
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
07 May 2026
EPS actual
-0.37 (-9.5%)
estimate -0.34
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
03 Mar 2026
EPS actual
-0.30 (+14.7%)
estimate -0.35
Revenue actual
0 (+100.0%)
estimate -52.0K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Amylyx Pharmaceuticals missed consensus estimates in its latest earnings report, with EPS of $-0.39 versus an estimate of $-0.3609, and revenue met expectations at $0. In the prior quarter, EPS also missed estimates while revenue again met expectations.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Joshua Cohen
Employees
123
IPO date
07 Jan 2022
ISIN
US03237H1014
Website
amylyx.com

Frequently asked questions

When does Amylyx Pharmaceuticals, Inc. (AMLX) next report earnings?

Amylyx Pharmaceuticals, Inc. (AMLX) is scheduled to report earnings on November 5, 2026.

What was Amylyx Pharmaceuticals, Inc.'s most recent earnings date?

Amylyx Pharmaceuticals, Inc. (AMLX) last reported earnings on August 6, 2026.

Where is Amylyx Pharmaceuticals, Inc. stock listed?

Amylyx Pharmaceuticals, Inc. (AMLX) is listed on Nasdaq.